Ethical considerations and management strategies for fertility preservation in women of reproductive age with malignant tumors: Chinese practices and perspectives - Report - MDSpire

Ethical considerations and management strategies for fertility preservation in women of reproductive age with malignant tumors: Chinese practices and perspectives

  • By

  • Ke Wang

  • Shihui Wang

  • Jianjiang Gao

  • Jiahuan Zhang

  • Jianqing Zhu

  • May 25, 2026

  • 0 min

Share

Ethical Aspects and Approaches to Fertility Preservation in Reproductive-Aged Women with Cancer

Overview

This report reviews the ethical and regulatory landscape of fertility preservation for reproductive-aged women with cancer in China, highlighting the effectiveness and safety of various techniques. It emphasizes the need for improved ethical regulations and multidisciplinary collaboration to support patients facing fertility loss due to cancer treatment.

Background

With approximately 2 million women diagnosed with malignant tumors annually, many face the risk of fertility loss from cancer treatments. The advancement of treatment technologies has improved survival rates, increasing the demand for effective fertility preservation strategies. Understanding the ethical implications and clinical practices surrounding these strategies is crucial for patient care.

Data Highlights

TechniqueSuccess RateNotes
Frozen mature oocytes80%-90% survival, 33% live birthLegal gray areas for unmarried patients
Embryo freezingHigher pregnancy rate than fresh embryosLimited to married patients
Ovarian tissue freezing37.7% pregnancy/live birth rateRisk of tumor cell reintroduction
In vitro maturation8.9% live birth rateDoes not require ovarian stimulation

Key Findings

  • Fertility preservation techniques include oocyte freezing, embryo freezing, ovarian tissue freezing, and in vitro maturation.
  • Patients have a significant need for fertility information, with anxiety and depression impacting decision-making.
  • Multidisciplinary collaboration can optimize treatment timing and balance tumor control with fertility protection.
  • Ethical challenges include decision-making autonomy and the rights related to frozen gametes.
  • Legal frameworks need improvement to address issues faced by unmarried patients regarding fertility preservation.

Clinical Implications

Healthcare providers should establish a patient-centered decision support system that incorporates psychological assessments and family communication. There is a need for improved ethical regulations and legal frameworks to address the complexities surrounding fertility preservation.

Conclusion

Fertility preservation for women with cancer requires a comprehensive approach that integrates ethical considerations, clinical practices, and social support to ensure patients' reproductive rights and health.

Related Resources & Content

  1. Frontiers in Reproductive Health, 2026 -- Ethics of non-oncological fertility preservation from the perspective of the four principles of bioethics
  2. The ASCO Post, 2012 -- Options for Preserving Fertility Should Be Considered Early to Maximize the Likelihood of Success
  3. The ASCO Post, 2025 -- ASCO Updates Guideline for Fertility Preservation in People With Cancer
  4. Frontiers in Oncology, 2026 -- Influencing factors of fertility concerns in cancer patients of childbearing age: a systematic review and meta-analysis
  5. Journal of Clinical Oncology, 2025 -- Fertility Preservation in People With Cancer: ASCO Guideline Update
  6. New England Journal of Medicine, 2023 -- Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer
  7. 人类辅助生殖技术管理办法 -- National Health Commission of China
  8. Fertility Preservation in People With Cancer: ASCO Guideline Update | Journal of Clinical Oncology
  9. Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer | New England Journal of Medicine
  10. 人类辅助生殖技术管理办法

Original Source(s)

Related Content